Vaidya Sane Ayur LAB Ltd
NSE: MADHAVBAUG · Other · sector
₹146.45NSE close 2026-10-23
Key numbers
Market cap₹155 cr
Price₹146.45
52w high / low₹335 / ₹140
P/E17.2xSector median 14.4x
P/B2.5xSector median 1.7x
Book value₹57.9
Dividend yield–Sector median 0.37%
ROE15.9%Sector median 13.8%
ROCE19.1%Sector median 19.6%
OPM14.4%Sector median 10.4%
Debt / equity–Sector median 0.29x
EV/EBITDA8.5xSector median 8.4x
Interest cover13.7x
Current ratio3.99x
Sales growth 3y+25.9%Sector median +7.7%
Profit growth 3y+62.4%Sector median +16.6%
PEG0.28x
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 13.7x in the last 12 months.
- Operating cash flow was below net profit in 3 of the last 4 years (FY26, FY24, FY23).
- Other income was 26% of net profit in the last 12 months.
- No dividend in the last 4 financial years.
- Price ₹146.45 on 2026-10-23: -56.3% from the 52-week high, +4.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹298.00 · low ₹89.10
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 99 | 51 | 48 | 42 | 48 | 50 | 57 |
| EBITDA | 8 | 3 | 2 | 6 | 7 | 9 | 7 |
| OPM % | 7.9% | 5.2% | 3.8% | 13.8% | 13.6% | 17.3% | 11.9% |
| Other income | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net profit | 5 | 1 | 1 | 3 | 3 | 5 | 4 |
| EPS (₹) | 4.60 | 1.12 | 0.76 | 3.59 | 3.17 | 4.56 | 3.95 |
| Revenue YoY | -51.5% | -2.3% | +18.1% | ||||
| Profit YoY | -29.4% | +309.3% | +420.0% |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 54 | 99 | 90 | 107 | 107 |
| EBITDA | 4 | 4 | 12 | 15 | 15 |
| Net profit | 2 | -0 | 7 | 9 | 9 |
| EPS (₹) | 1.99 | 1.88 | 6.76 | 8.51 | 8.51 |
| Revenue growth | +85.4% | -9.5% | +19.0% | – | |
| Profit growth | -100.5% | – | +25.4% | – | |
| Dividend / share (₹) | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +25.9% | – | – |
| Net profit | +62.4% | – | – |
| EPS | +62.3% | – | – |
| Share price | – | +6.1% (2y) | -43.0% |
Balance sheet
| ₹ cr | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Shareholders' equity | – | – | 52 | 61 |
| Cash & equivalents | – | – | 17 | 23 |
| Total assets | – | – | 77 | 105 |
| Fixed assets | – | – | 21 | 22 |
| Investments | – | – | 6 | 17 |
| Inventory | – | – | 4 | 4 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Cash from operations | 0 | -4 | 11 | 5 |
| Cash from investing | 1 | 1 | -10 | -24 |
| Cash from financing | -1 | 14 | -1 | 17 |
| Capex | 0 | 0 | 8 | 8 |
| Free cash flow | 0 | -4 | 2 | -2 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ROE % | – | – | 13.8% | 14.7% |
| ROCE % | – | – | 19.2% | 19.1% |
| Inventory days | – | – | 82 | 70 |
| Working capital days | – | – | 77 | 113 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| MADHAVBAUG | ₹155 cr | 17.2x | 2.5x | 15.9% | 19.1% | 14.4% | +25.9% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| sale of Product Activity | ₹72 cr | 67.0% | ₹17 cr | 24.3% |
| Hospital Activity | ₹29 cr | 26.8% | ₹16 cr | 57.2% |
| Common/ Unallocable | ₹7 cr | 6.2% | ₹60 cr | 902.0% |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | MADHAVBAUG |
| BSE code | – |
| ISIN | INE0JR301013 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-23.